Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study.

<h4>Background</h4>The ten-valent pneumococcal conjugate vaccine (PCV10) was introduced into the Finnish National Vaccination Program (NVP) in September 2010 with a 2+1 schedule (3, 5, 12 months) without catch-up vaccinations. We evaluated the direct and indirect effects of PCV10 on inva...

Full description

Bibliographic Details
Main Authors: Jukka Jokinen, Hanna Rinta-Kokko, Lotta Siira, Arto A Palmu, Mikko J Virtanen, Hanna Nohynek, Anni Virolainen-Julkunen, Maija Toropainen, J Pekka Nuorti
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0120290
_version_ 1818837875219759104
author Jukka Jokinen
Hanna Rinta-Kokko
Lotta Siira
Arto A Palmu
Mikko J Virtanen
Hanna Nohynek
Anni Virolainen-Julkunen
Maija Toropainen
J Pekka Nuorti
author_facet Jukka Jokinen
Hanna Rinta-Kokko
Lotta Siira
Arto A Palmu
Mikko J Virtanen
Hanna Nohynek
Anni Virolainen-Julkunen
Maija Toropainen
J Pekka Nuorti
author_sort Jukka Jokinen
collection DOAJ
description <h4>Background</h4>The ten-valent pneumococcal conjugate vaccine (PCV10) was introduced into the Finnish National Vaccination Program (NVP) in September 2010 with a 2+1 schedule (3, 5, 12 months) without catch-up vaccinations. We evaluated the direct and indirect effects of PCV10 on invasive pneumococcal disease (IPD) among children ≤5 years of age during the first three years after NVP introduction.<h4>Methods</h4>We conducted a population-based, observational follow-up study. The cohort of vaccine-eligible children (all children born June 1, 2010 or later) was followed from 3 months of age until the end of 2013. For the indirect effect, another cohort of older children ineligible for PCV10 vaccination was followed from 2011 through 2013. Both cohorts were compared with season- and age-matched reference cohorts before NVP introduction. National, population-based laboratory surveillance data were used to compare culture-confirmed serotype-specific IPD rates in the vaccine target and reference cohorts by using Poisson regression models.<h4>Results</h4>The overall IPD rate among vaccine-eligible children was reduced by 80% (95%CI 72 to 85); the reduction in vaccine-type IPD was 92% (95%CI 86 to 95). However, a non-significant increase in non-vaccine type IPD was observed. During 2012-2013, we also observed a 48% (95%CI 18 to 69) reduction in IPD among unvaccinated children 2 to 5 years of age, which was mostly attributable to the ten vaccine serotypes.<h4>Conclusions</h4>This is the first population-based study investigating the impact of PCV10 introduction without prior PCV7 use. A substantial decrease in IPD rates among vaccine-eligible children was observed. A smaller and temporally delayed reduction among older, unvaccinated children suggests that PCV10 also provides indirect protection against vaccine-type IPD. Changes in serotype distribution warrant continuous monitoring of potential increases in non-vaccine serotypes.
first_indexed 2024-12-19T03:29:27Z
format Article
id doaj.art-93293d1dd8b24478ac51ffb67fe17f9f
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-19T03:29:27Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-93293d1dd8b24478ac51ffb67fe17f9f2022-12-21T20:37:32ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01103e012029010.1371/journal.pone.0120290Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study.Jukka JokinenHanna Rinta-KokkoLotta SiiraArto A PalmuMikko J VirtanenHanna NohynekAnni Virolainen-JulkunenMaija ToropainenJ Pekka Nuorti<h4>Background</h4>The ten-valent pneumococcal conjugate vaccine (PCV10) was introduced into the Finnish National Vaccination Program (NVP) in September 2010 with a 2+1 schedule (3, 5, 12 months) without catch-up vaccinations. We evaluated the direct and indirect effects of PCV10 on invasive pneumococcal disease (IPD) among children ≤5 years of age during the first three years after NVP introduction.<h4>Methods</h4>We conducted a population-based, observational follow-up study. The cohort of vaccine-eligible children (all children born June 1, 2010 or later) was followed from 3 months of age until the end of 2013. For the indirect effect, another cohort of older children ineligible for PCV10 vaccination was followed from 2011 through 2013. Both cohorts were compared with season- and age-matched reference cohorts before NVP introduction. National, population-based laboratory surveillance data were used to compare culture-confirmed serotype-specific IPD rates in the vaccine target and reference cohorts by using Poisson regression models.<h4>Results</h4>The overall IPD rate among vaccine-eligible children was reduced by 80% (95%CI 72 to 85); the reduction in vaccine-type IPD was 92% (95%CI 86 to 95). However, a non-significant increase in non-vaccine type IPD was observed. During 2012-2013, we also observed a 48% (95%CI 18 to 69) reduction in IPD among unvaccinated children 2 to 5 years of age, which was mostly attributable to the ten vaccine serotypes.<h4>Conclusions</h4>This is the first population-based study investigating the impact of PCV10 introduction without prior PCV7 use. A substantial decrease in IPD rates among vaccine-eligible children was observed. A smaller and temporally delayed reduction among older, unvaccinated children suggests that PCV10 also provides indirect protection against vaccine-type IPD. Changes in serotype distribution warrant continuous monitoring of potential increases in non-vaccine serotypes.https://doi.org/10.1371/journal.pone.0120290
spellingShingle Jukka Jokinen
Hanna Rinta-Kokko
Lotta Siira
Arto A Palmu
Mikko J Virtanen
Hanna Nohynek
Anni Virolainen-Julkunen
Maija Toropainen
J Pekka Nuorti
Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study.
PLoS ONE
title Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study.
title_full Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study.
title_fullStr Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study.
title_full_unstemmed Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study.
title_short Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study.
title_sort impact of ten valent pneumococcal conjugate vaccination on invasive pneumococcal disease in finnish children a population based study
url https://doi.org/10.1371/journal.pone.0120290
work_keys_str_mv AT jukkajokinen impactoftenvalentpneumococcalconjugatevaccinationoninvasivepneumococcaldiseaseinfinnishchildrenapopulationbasedstudy
AT hannarintakokko impactoftenvalentpneumococcalconjugatevaccinationoninvasivepneumococcaldiseaseinfinnishchildrenapopulationbasedstudy
AT lottasiira impactoftenvalentpneumococcalconjugatevaccinationoninvasivepneumococcaldiseaseinfinnishchildrenapopulationbasedstudy
AT artoapalmu impactoftenvalentpneumococcalconjugatevaccinationoninvasivepneumococcaldiseaseinfinnishchildrenapopulationbasedstudy
AT mikkojvirtanen impactoftenvalentpneumococcalconjugatevaccinationoninvasivepneumococcaldiseaseinfinnishchildrenapopulationbasedstudy
AT hannanohynek impactoftenvalentpneumococcalconjugatevaccinationoninvasivepneumococcaldiseaseinfinnishchildrenapopulationbasedstudy
AT annivirolainenjulkunen impactoftenvalentpneumococcalconjugatevaccinationoninvasivepneumococcaldiseaseinfinnishchildrenapopulationbasedstudy
AT maijatoropainen impactoftenvalentpneumococcalconjugatevaccinationoninvasivepneumococcaldiseaseinfinnishchildrenapopulationbasedstudy
AT jpekkanuorti impactoftenvalentpneumococcalconjugatevaccinationoninvasivepneumococcaldiseaseinfinnishchildrenapopulationbasedstudy